home All News open_in_new Full Article

Breast cancer treatment breakthrough for patients as NHS approves new 'landmark' drug

Thousands with advanced breast cancer could live long lives thanks to a new drug approved on the NHS. Capivasertib, retailed as Truqap, targets the most common type of breast cancer and stops it spreading. Up to 3,000 women could benefit from the treatment each year, with experts last night hailing it “a great success story for British science.”


today 5 d. ago attach_file Science

attach_file Science
attach_file Politics
attach_file Science
attach_file Events
attach_file Politics
attach_file Politics


ID: 383884443
Add Watch Country

arrow_drop_down